The identification of key immune-modulating genes like ISG15, SERPING1, C1QA, C1QB, and VSIG4 opens avenues for therapeutic approaches that aim to modulate the immune response and improve outcomes in severe COVID-19 cases via upregulation of expression of these genes. This evidence concerns the gene ISG15 and COVID-19.